nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—TOP2A—Epirubicin—thyroid cancer	0.186	0.257	CbGbCtD
Ofloxacin—ABCC1—Vandetanib—thyroid cancer	0.15	0.207	CbGbCtD
Ofloxacin—ABCC1—Epirubicin—thyroid cancer	0.103	0.142	CbGbCtD
Ofloxacin—TOP2A—Doxorubicin—thyroid cancer	0.0991	0.136	CbGbCtD
Ofloxacin—ABCC2—Sorafenib—thyroid cancer	0.067	0.0922	CbGbCtD
Ofloxacin—ABCC1—Doxorubicin—thyroid cancer	0.0549	0.0756	CbGbCtD
Ofloxacin—ABCC2—Doxorubicin—thyroid cancer	0.0406	0.0559	CbGbCtD
Ofloxacin—CYP1A2—Sorafenib—thyroid cancer	0.025	0.0344	CbGbCtD
Ofloxacin—SLC22A4—larynx—thyroid cancer	0.0058	0.373	CbGeAlD
Ofloxacin—TOP2A—Erlotinib—Vandetanib—thyroid cancer	0.00172	0.312	CbGdCrCtD
Ofloxacin—SLC22A4—neck—thyroid cancer	0.00154	0.099	CbGeAlD
Ofloxacin—TOP2A—Afatinib—Vandetanib—thyroid cancer	0.00113	0.204	CbGdCrCtD
Ofloxacin—TOP2A—Gefitinib—Vandetanib—thyroid cancer	0.000983	0.178	CbGdCrCtD
Ofloxacin—SLC22A4—trachea—thyroid cancer	0.000926	0.0595	CbGeAlD
Ofloxacin—TOP2A—thyroid gland—thyroid cancer	0.000915	0.0589	CbGeAlD
Ofloxacin—SLC22A5—saliva-secreting gland—thyroid cancer	0.000794	0.0511	CbGeAlD
Ofloxacin—SLC22A4—thyroid gland—thyroid cancer	0.000732	0.0471	CbGeAlD
Ofloxacin—ABCC1—trachea—thyroid cancer	0.000697	0.0448	CbGeAlD
Ofloxacin—SLC22A5—trachea—thyroid cancer	0.000613	0.0394	CbGeAlD
Ofloxacin—TOP2A—lymph node—thyroid cancer	0.000568	0.0366	CbGeAlD
Ofloxacin—ABCC1—thyroid gland—thyroid cancer	0.000551	0.0354	CbGeAlD
Ofloxacin—SLC22A5—thyroid gland—thyroid cancer	0.000485	0.0312	CbGeAlD
Ofloxacin—SLC22A4—lymph node—thyroid cancer	0.000455	0.0293	CbGeAlD
Ofloxacin—CYP1A2—thyroid gland—thyroid cancer	0.000439	0.0282	CbGeAlD
Ofloxacin—ABCC2—lymph node—thyroid cancer	0.000389	0.025	CbGeAlD
Ofloxacin—ABCC1—lymph node—thyroid cancer	0.000342	0.022	CbGeAlD
Ofloxacin—SLC22A5—lymph node—thyroid cancer	0.000301	0.0194	CbGeAlD
Ofloxacin—TOP2A—Idarubicin—Epirubicin—thyroid cancer	0.000292	0.0529	CbGdCrCtD
Ofloxacin—TOP2A—Doxorubicin—Epirubicin—thyroid cancer	0.000292	0.0529	CbGdCrCtD
Ofloxacin—TOP2A—Daunorubicin—Epirubicin—thyroid cancer	0.000292	0.0529	CbGdCrCtD
Ofloxacin—TOP2A—Idarubicin—Doxorubicin—thyroid cancer	0.00027	0.049	CbGdCrCtD
Ofloxacin—TOP2A—Daunorubicin—Doxorubicin—thyroid cancer	0.00027	0.049	CbGdCrCtD
Ofloxacin—TOP2A—Epirubicin—Doxorubicin—thyroid cancer	0.00027	0.049	CbGdCrCtD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCDC6—thyroid cancer	0.000269	0.123	CbGpPWpGaD
Ofloxacin—Asthma—Epirubicin—thyroid cancer	0.00014	0.000558	CcSEcCtD
Ofloxacin—Dysphagia—Epirubicin—thyroid cancer	0.00014	0.000558	CcSEcCtD
Ofloxacin—Dehydration—Doxorubicin—thyroid cancer	0.000139	0.000556	CcSEcCtD
Ofloxacin—Eosinophilia—Epirubicin—thyroid cancer	0.000138	0.000553	CcSEcCtD
Ofloxacin—Dry skin—Doxorubicin—thyroid cancer	0.000137	0.000548	CcSEcCtD
Ofloxacin—Pancreatitis—Epirubicin—thyroid cancer	0.000137	0.000547	CcSEcCtD
Ofloxacin—Vomiting—Sorafenib—thyroid cancer	0.000137	0.000546	CcSEcCtD
Ofloxacin—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000137	0.000546	CcSEcCtD
Ofloxacin—Hypokalaemia—Doxorubicin—thyroid cancer	0.000136	0.000544	CcSEcCtD
Ofloxacin—Angina pectoris—Epirubicin—thyroid cancer	0.000136	0.000544	CcSEcCtD
Ofloxacin—Rash—Sorafenib—thyroid cancer	0.000136	0.000541	CcSEcCtD
Ofloxacin—Dermatitis—Sorafenib—thyroid cancer	0.000135	0.000541	CcSEcCtD
Ofloxacin—Breast disorder—Doxorubicin—thyroid cancer	0.000135	0.00054	CcSEcCtD
Ofloxacin—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000135	0.000538	CcSEcCtD
Ofloxacin—Headache—Sorafenib—thyroid cancer	0.000135	0.000538	CcSEcCtD
Ofloxacin—Bronchitis—Epirubicin—thyroid cancer	0.000134	0.000537	CcSEcCtD
Ofloxacin—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000134	0.000534	CcSEcCtD
Ofloxacin—Pancytopenia—Epirubicin—thyroid cancer	0.000133	0.00053	CcSEcCtD
Ofloxacin—Gastritis—Doxorubicin—thyroid cancer	0.000132	0.000529	CcSEcCtD
Ofloxacin—Dysuria—Epirubicin—thyroid cancer	0.000131	0.000522	CcSEcCtD
Ofloxacin—Neutropenia—Epirubicin—thyroid cancer	0.000131	0.000522	CcSEcCtD
Ofloxacin—Abdominal distension—Doxorubicin—thyroid cancer	0.00013	0.00052	CcSEcCtD
Ofloxacin—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00013	0.000519	CcSEcCtD
Ofloxacin—Asthma—Doxorubicin—thyroid cancer	0.000129	0.000516	CcSEcCtD
Ofloxacin—Dysphagia—Doxorubicin—thyroid cancer	0.000129	0.000516	CcSEcCtD
Ofloxacin—Pollakiuria—Epirubicin—thyroid cancer	0.000129	0.000516	CcSEcCtD
Ofloxacin—Eosinophilia—Doxorubicin—thyroid cancer	0.000128	0.000511	CcSEcCtD
Ofloxacin—Nausea—Sorafenib—thyroid cancer	0.000128	0.00051	CcSEcCtD
Ofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—TCF7L1—thyroid cancer	0.000128	0.0586	CbGpPWpGaD
Ofloxacin—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000128	0.000509	CcSEcCtD
Ofloxacin—Pancreatitis—Doxorubicin—thyroid cancer	0.000127	0.000506	CcSEcCtD
Ofloxacin—Weight decreased—Epirubicin—thyroid cancer	0.000126	0.000505	CcSEcCtD
Ofloxacin—Hyperglycaemia—Epirubicin—thyroid cancer	0.000126	0.000503	CcSEcCtD
Ofloxacin—Angina pectoris—Doxorubicin—thyroid cancer	0.000126	0.000503	CcSEcCtD
Ofloxacin—Pneumonia—Epirubicin—thyroid cancer	0.000125	0.000501	CcSEcCtD
Ofloxacin—Infestation—Epirubicin—thyroid cancer	0.000125	0.000498	CcSEcCtD
Ofloxacin—Infestation NOS—Epirubicin—thyroid cancer	0.000125	0.000498	CcSEcCtD
Ofloxacin—Drowsiness—Epirubicin—thyroid cancer	0.000125	0.000498	CcSEcCtD
Ofloxacin—Bronchitis—Doxorubicin—thyroid cancer	0.000124	0.000497	CcSEcCtD
Ofloxacin—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000124	0.000493	CcSEcCtD
Ofloxacin—Pancytopenia—Doxorubicin—thyroid cancer	0.000123	0.00049	CcSEcCtD
Ofloxacin—Renal failure—Epirubicin—thyroid cancer	0.000122	0.000489	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000122	0.000488	CcSEcCtD
Ofloxacin—Jaundice—Epirubicin—thyroid cancer	0.000121	0.000485	CcSEcCtD
Ofloxacin—Stomatitis—Epirubicin—thyroid cancer	0.000121	0.000485	CcSEcCtD
Ofloxacin—Conjunctivitis—Epirubicin—thyroid cancer	0.000121	0.000484	CcSEcCtD
Ofloxacin—Dysuria—Doxorubicin—thyroid cancer	0.000121	0.000483	CcSEcCtD
Ofloxacin—Neutropenia—Doxorubicin—thyroid cancer	0.000121	0.000483	CcSEcCtD
Ofloxacin—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00012	0.00048	CcSEcCtD
Ofloxacin—Pollakiuria—Doxorubicin—thyroid cancer	0.000119	0.000477	CcSEcCtD
Ofloxacin—Haematuria—Epirubicin—thyroid cancer	0.000119	0.000474	CcSEcCtD
Ofloxacin—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000118	0.000471	CcSEcCtD
Ofloxacin—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000118	0.000471	CcSEcCtD
Ofloxacin—Epistaxis—Epirubicin—thyroid cancer	0.000118	0.000469	CcSEcCtD
Ofloxacin—Weight decreased—Doxorubicin—thyroid cancer	0.000117	0.000467	CcSEcCtD
Ofloxacin—Sinusitis—Epirubicin—thyroid cancer	0.000117	0.000467	CcSEcCtD
Ofloxacin—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000117	0.000466	CcSEcCtD
Ofloxacin—Agranulocytosis—Epirubicin—thyroid cancer	0.000116	0.000464	CcSEcCtD
Ofloxacin—Pneumonia—Doxorubicin—thyroid cancer	0.000116	0.000463	CcSEcCtD
Ofloxacin—Drowsiness—Doxorubicin—thyroid cancer	0.000115	0.00046	CcSEcCtD
Ofloxacin—Infestation NOS—Doxorubicin—thyroid cancer	0.000115	0.00046	CcSEcCtD
Ofloxacin—Infestation—Doxorubicin—thyroid cancer	0.000115	0.00046	CcSEcCtD
Ofloxacin—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000114	0.000457	CcSEcCtD
Ofloxacin—Bradycardia—Epirubicin—thyroid cancer	0.000114	0.000455	CcSEcCtD
Ofloxacin—Renal failure—Doxorubicin—thyroid cancer	0.000113	0.000453	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000113	0.000451	CcSEcCtD
Ofloxacin—Haemoglobin—Epirubicin—thyroid cancer	0.000112	0.000449	CcSEcCtD
Ofloxacin—Jaundice—Doxorubicin—thyroid cancer	0.000112	0.000449	CcSEcCtD
Ofloxacin—Stomatitis—Doxorubicin—thyroid cancer	0.000112	0.000449	CcSEcCtD
Ofloxacin—Rhinitis—Epirubicin—thyroid cancer	0.000112	0.000448	CcSEcCtD
Ofloxacin—Conjunctivitis—Doxorubicin—thyroid cancer	0.000112	0.000448	CcSEcCtD
Ofloxacin—Haemorrhage—Epirubicin—thyroid cancer	0.000112	0.000447	CcSEcCtD
Ofloxacin—Hepatitis—Epirubicin—thyroid cancer	0.000112	0.000447	CcSEcCtD
Ofloxacin—Hypoaesthesia—Epirubicin—thyroid cancer	0.000111	0.000444	CcSEcCtD
Ofloxacin—Pharyngitis—Epirubicin—thyroid cancer	0.000111	0.000443	CcSEcCtD
Ofloxacin—Urinary tract disorder—Epirubicin—thyroid cancer	0.00011	0.000441	CcSEcCtD
Ofloxacin—Oedema peripheral—Epirubicin—thyroid cancer	0.00011	0.00044	CcSEcCtD
Ofloxacin—Haematuria—Doxorubicin—thyroid cancer	0.00011	0.000439	CcSEcCtD
Ofloxacin—Connective tissue disorder—Epirubicin—thyroid cancer	0.00011	0.000439	CcSEcCtD
Ofloxacin—Urethral disorder—Epirubicin—thyroid cancer	0.00011	0.000438	CcSEcCtD
Ofloxacin—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000109	0.000435	CcSEcCtD
Ofloxacin—Epistaxis—Doxorubicin—thyroid cancer	0.000109	0.000434	CcSEcCtD
Ofloxacin—Sinusitis—Doxorubicin—thyroid cancer	0.000108	0.000432	CcSEcCtD
Ofloxacin—Visual impairment—Epirubicin—thyroid cancer	0.000108	0.000431	CcSEcCtD
Ofloxacin—Agranulocytosis—Doxorubicin—thyroid cancer	0.000108	0.00043	CcSEcCtD
Ofloxacin—ABCC1—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000107	0.0492	CbGpPWpGaD
Ofloxacin—Erythema multiforme—Epirubicin—thyroid cancer	0.000106	0.000422	CcSEcCtD
Ofloxacin—Bradycardia—Doxorubicin—thyroid cancer	0.000105	0.000421	CcSEcCtD
Ofloxacin—TOP2A—G0 and Early G1—CDK1—thyroid cancer	0.000105	0.0482	CbGpPWpGaD
Ofloxacin—Eye disorder—Epirubicin—thyroid cancer	0.000105	0.000417	CcSEcCtD
Ofloxacin—Tinnitus—Epirubicin—thyroid cancer	0.000104	0.000417	CcSEcCtD
Ofloxacin—Haemoglobin—Doxorubicin—thyroid cancer	0.000104	0.000415	CcSEcCtD
Ofloxacin—Flushing—Epirubicin—thyroid cancer	0.000104	0.000415	CcSEcCtD
Ofloxacin—Cardiac disorder—Epirubicin—thyroid cancer	0.000104	0.000415	CcSEcCtD
Ofloxacin—Rhinitis—Doxorubicin—thyroid cancer	0.000104	0.000414	CcSEcCtD
Ofloxacin—Haemorrhage—Doxorubicin—thyroid cancer	0.000103	0.000413	CcSEcCtD
Ofloxacin—Hepatitis—Doxorubicin—thyroid cancer	0.000103	0.000413	CcSEcCtD
Ofloxacin—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000103	0.000411	CcSEcCtD
Ofloxacin—Pharyngitis—Doxorubicin—thyroid cancer	0.000103	0.00041	CcSEcCtD
Ofloxacin—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000102	0.000408	CcSEcCtD
Ofloxacin—Oedema peripheral—Doxorubicin—thyroid cancer	0.000102	0.000407	CcSEcCtD
Ofloxacin—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000102	0.000406	CcSEcCtD
Ofloxacin—Angiopathy—Epirubicin—thyroid cancer	0.000101	0.000405	CcSEcCtD
Ofloxacin—Urethral disorder—Doxorubicin—thyroid cancer	0.000101	0.000405	CcSEcCtD
Ofloxacin—Immune system disorder—Epirubicin—thyroid cancer	0.000101	0.000404	CcSEcCtD
Ofloxacin—Mediastinal disorder—Epirubicin—thyroid cancer	0.000101	0.000403	CcSEcCtD
Ofloxacin—Chills—Epirubicin—thyroid cancer	0.0001	0.000401	CcSEcCtD
Ofloxacin—Arrhythmia—Epirubicin—thyroid cancer	9.99e-05	0.000399	CcSEcCtD
Ofloxacin—Visual impairment—Doxorubicin—thyroid cancer	9.97e-05	0.000398	CcSEcCtD
Ofloxacin—Alopecia—Epirubicin—thyroid cancer	9.88e-05	0.000395	CcSEcCtD
Ofloxacin—Mental disorder—Epirubicin—thyroid cancer	9.8e-05	0.000391	CcSEcCtD
Ofloxacin—Erythema multiforme—Doxorubicin—thyroid cancer	9.78e-05	0.000391	CcSEcCtD
Ofloxacin—Erythema—Epirubicin—thyroid cancer	9.74e-05	0.000389	CcSEcCtD
Ofloxacin—Malnutrition—Epirubicin—thyroid cancer	9.74e-05	0.000389	CcSEcCtD
Ofloxacin—Eye disorder—Doxorubicin—thyroid cancer	9.67e-05	0.000386	CcSEcCtD
Ofloxacin—Tinnitus—Doxorubicin—thyroid cancer	9.65e-05	0.000385	CcSEcCtD
Ofloxacin—Flushing—Doxorubicin—thyroid cancer	9.6e-05	0.000384	CcSEcCtD
Ofloxacin—Cardiac disorder—Doxorubicin—thyroid cancer	9.6e-05	0.000384	CcSEcCtD
Ofloxacin—Flatulence—Epirubicin—thyroid cancer	9.59e-05	0.000383	CcSEcCtD
Ofloxacin—Tension—Epirubicin—thyroid cancer	9.55e-05	0.000382	CcSEcCtD
Ofloxacin—Dysgeusia—Epirubicin—thyroid cancer	9.53e-05	0.000381	CcSEcCtD
Ofloxacin—Nervousness—Epirubicin—thyroid cancer	9.46e-05	0.000378	CcSEcCtD
Ofloxacin—Back pain—Epirubicin—thyroid cancer	9.42e-05	0.000376	CcSEcCtD
Ofloxacin—Angiopathy—Doxorubicin—thyroid cancer	9.39e-05	0.000375	CcSEcCtD
Ofloxacin—Muscle spasms—Epirubicin—thyroid cancer	9.36e-05	0.000374	CcSEcCtD
Ofloxacin—Immune system disorder—Doxorubicin—thyroid cancer	9.35e-05	0.000373	CcSEcCtD
Ofloxacin—Mediastinal disorder—Doxorubicin—thyroid cancer	9.33e-05	0.000373	CcSEcCtD
Ofloxacin—Chills—Doxorubicin—thyroid cancer	9.29e-05	0.000371	CcSEcCtD
Ofloxacin—Arrhythmia—Doxorubicin—thyroid cancer	9.24e-05	0.000369	CcSEcCtD
Ofloxacin—Vision blurred—Epirubicin—thyroid cancer	9.18e-05	0.000367	CcSEcCtD
Ofloxacin—Alopecia—Doxorubicin—thyroid cancer	9.14e-05	0.000365	CcSEcCtD
Ofloxacin—Mental disorder—Doxorubicin—thyroid cancer	9.07e-05	0.000362	CcSEcCtD
Ofloxacin—Ill-defined disorder—Epirubicin—thyroid cancer	9.03e-05	0.000361	CcSEcCtD
Ofloxacin—Erythema—Doxorubicin—thyroid cancer	9.01e-05	0.00036	CcSEcCtD
Ofloxacin—Malnutrition—Doxorubicin—thyroid cancer	9.01e-05	0.00036	CcSEcCtD
Ofloxacin—Anaemia—Epirubicin—thyroid cancer	9e-05	0.000359	CcSEcCtD
Ofloxacin—Agitation—Epirubicin—thyroid cancer	8.95e-05	0.000357	CcSEcCtD
Ofloxacin—Flatulence—Doxorubicin—thyroid cancer	8.88e-05	0.000355	CcSEcCtD
Ofloxacin—Tension—Doxorubicin—thyroid cancer	8.84e-05	0.000353	CcSEcCtD
Ofloxacin—Dysgeusia—Doxorubicin—thyroid cancer	8.82e-05	0.000352	CcSEcCtD
Ofloxacin—Malaise—Epirubicin—thyroid cancer	8.78e-05	0.000351	CcSEcCtD
Ofloxacin—Nervousness—Doxorubicin—thyroid cancer	8.75e-05	0.000349	CcSEcCtD
Ofloxacin—Vertigo—Epirubicin—thyroid cancer	8.75e-05	0.000349	CcSEcCtD
Ofloxacin—Syncope—Epirubicin—thyroid cancer	8.73e-05	0.000349	CcSEcCtD
Ofloxacin—Leukopenia—Epirubicin—thyroid cancer	8.72e-05	0.000348	CcSEcCtD
Ofloxacin—Back pain—Doxorubicin—thyroid cancer	8.71e-05	0.000348	CcSEcCtD
Ofloxacin—Muscle spasms—Doxorubicin—thyroid cancer	8.66e-05	0.000346	CcSEcCtD
Ofloxacin—Palpitations—Epirubicin—thyroid cancer	8.6e-05	0.000344	CcSEcCtD
Ofloxacin—Loss of consciousness—Epirubicin—thyroid cancer	8.56e-05	0.000342	CcSEcCtD
Ofloxacin—Cough—Epirubicin—thyroid cancer	8.5e-05	0.000339	CcSEcCtD
Ofloxacin—Vision blurred—Doxorubicin—thyroid cancer	8.49e-05	0.000339	CcSEcCtD
Ofloxacin—Hypertension—Epirubicin—thyroid cancer	8.41e-05	0.000336	CcSEcCtD
Ofloxacin—Ill-defined disorder—Doxorubicin—thyroid cancer	8.36e-05	0.000334	CcSEcCtD
Ofloxacin—Anaemia—Doxorubicin—thyroid cancer	8.33e-05	0.000333	CcSEcCtD
Ofloxacin—Chest pain—Epirubicin—thyroid cancer	8.29e-05	0.000331	CcSEcCtD
Ofloxacin—Arthralgia—Epirubicin—thyroid cancer	8.29e-05	0.000331	CcSEcCtD
Ofloxacin—Myalgia—Epirubicin—thyroid cancer	8.29e-05	0.000331	CcSEcCtD
Ofloxacin—Agitation—Doxorubicin—thyroid cancer	8.28e-05	0.000331	CcSEcCtD
Ofloxacin—Anxiety—Epirubicin—thyroid cancer	8.26e-05	0.00033	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	8.23e-05	0.000329	CcSEcCtD
Ofloxacin—Discomfort—Epirubicin—thyroid cancer	8.19e-05	0.000327	CcSEcCtD
Ofloxacin—Malaise—Doxorubicin—thyroid cancer	8.12e-05	0.000324	CcSEcCtD
Ofloxacin—Dry mouth—Epirubicin—thyroid cancer	8.11e-05	0.000324	CcSEcCtD
Ofloxacin—Vertigo—Doxorubicin—thyroid cancer	8.09e-05	0.000323	CcSEcCtD
Ofloxacin—Syncope—Doxorubicin—thyroid cancer	8.08e-05	0.000323	CcSEcCtD
Ofloxacin—Leukopenia—Doxorubicin—thyroid cancer	8.06e-05	0.000322	CcSEcCtD
Ofloxacin—Confusional state—Epirubicin—thyroid cancer	8.01e-05	0.00032	CcSEcCtD
Ofloxacin—Palpitations—Doxorubicin—thyroid cancer	7.96e-05	0.000318	CcSEcCtD
Ofloxacin—Anaphylactic shock—Epirubicin—thyroid cancer	7.95e-05	0.000317	CcSEcCtD
Ofloxacin—Oedema—Epirubicin—thyroid cancer	7.95e-05	0.000317	CcSEcCtD
Ofloxacin—Loss of consciousness—Doxorubicin—thyroid cancer	7.92e-05	0.000316	CcSEcCtD
Ofloxacin—Infection—Epirubicin—thyroid cancer	7.89e-05	0.000315	CcSEcCtD
Ofloxacin—Cough—Doxorubicin—thyroid cancer	7.86e-05	0.000314	CcSEcCtD
Ofloxacin—Shock—Epirubicin—thyroid cancer	7.82e-05	0.000312	CcSEcCtD
Ofloxacin—Nervous system disorder—Epirubicin—thyroid cancer	7.79e-05	0.000311	CcSEcCtD
Ofloxacin—Thrombocytopenia—Epirubicin—thyroid cancer	7.78e-05	0.000311	CcSEcCtD
Ofloxacin—Hypertension—Doxorubicin—thyroid cancer	7.78e-05	0.000311	CcSEcCtD
Ofloxacin—Tachycardia—Epirubicin—thyroid cancer	7.76e-05	0.00031	CcSEcCtD
Ofloxacin—Skin disorder—Epirubicin—thyroid cancer	7.72e-05	0.000308	CcSEcCtD
Ofloxacin—Hyperhidrosis—Epirubicin—thyroid cancer	7.68e-05	0.000307	CcSEcCtD
Ofloxacin—Chest pain—Doxorubicin—thyroid cancer	7.67e-05	0.000306	CcSEcCtD
Ofloxacin—Myalgia—Doxorubicin—thyroid cancer	7.67e-05	0.000306	CcSEcCtD
Ofloxacin—Arthralgia—Doxorubicin—thyroid cancer	7.67e-05	0.000306	CcSEcCtD
Ofloxacin—Anxiety—Doxorubicin—thyroid cancer	7.64e-05	0.000305	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	7.62e-05	0.000304	CcSEcCtD
Ofloxacin—Discomfort—Doxorubicin—thyroid cancer	7.58e-05	0.000303	CcSEcCtD
Ofloxacin—Anorexia—Epirubicin—thyroid cancer	7.57e-05	0.000303	CcSEcCtD
Ofloxacin—Dry mouth—Doxorubicin—thyroid cancer	7.5e-05	0.0003	CcSEcCtD
Ofloxacin—Hypotension—Epirubicin—thyroid cancer	7.43e-05	0.000297	CcSEcCtD
Ofloxacin—Confusional state—Doxorubicin—thyroid cancer	7.41e-05	0.000296	CcSEcCtD
Ofloxacin—Oedema—Doxorubicin—thyroid cancer	7.35e-05	0.000294	CcSEcCtD
Ofloxacin—Anaphylactic shock—Doxorubicin—thyroid cancer	7.35e-05	0.000294	CcSEcCtD
Ofloxacin—Infection—Doxorubicin—thyroid cancer	7.3e-05	0.000292	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	7.24e-05	0.000289	CcSEcCtD
Ofloxacin—Shock—Doxorubicin—thyroid cancer	7.23e-05	0.000289	CcSEcCtD
Ofloxacin—Nervous system disorder—Doxorubicin—thyroid cancer	7.21e-05	0.000288	CcSEcCtD
Ofloxacin—Thrombocytopenia—Doxorubicin—thyroid cancer	7.2e-05	0.000288	CcSEcCtD
Ofloxacin—Insomnia—Epirubicin—thyroid cancer	7.19e-05	0.000287	CcSEcCtD
Ofloxacin—Tachycardia—Doxorubicin—thyroid cancer	7.18e-05	0.000287	CcSEcCtD
Ofloxacin—Skin disorder—Doxorubicin—thyroid cancer	7.14e-05	0.000285	CcSEcCtD
Ofloxacin—Paraesthesia—Epirubicin—thyroid cancer	7.14e-05	0.000285	CcSEcCtD
Ofloxacin—Hyperhidrosis—Doxorubicin—thyroid cancer	7.11e-05	0.000284	CcSEcCtD
Ofloxacin—Dyspnoea—Epirubicin—thyroid cancer	7.08e-05	0.000283	CcSEcCtD
Ofloxacin—Somnolence—Epirubicin—thyroid cancer	7.06e-05	0.000282	CcSEcCtD
Ofloxacin—Anorexia—Doxorubicin—thyroid cancer	7.01e-05	0.00028	CcSEcCtD
Ofloxacin—Dyspepsia—Epirubicin—thyroid cancer	6.99e-05	0.000279	CcSEcCtD
Ofloxacin—Decreased appetite—Epirubicin—thyroid cancer	6.91e-05	0.000276	CcSEcCtD
Ofloxacin—Hypotension—Doxorubicin—thyroid cancer	6.87e-05	0.000274	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Epirubicin—thyroid cancer	6.86e-05	0.000274	CcSEcCtD
Ofloxacin—Fatigue—Epirubicin—thyroid cancer	6.85e-05	0.000274	CcSEcCtD
Ofloxacin—Pain—Epirubicin—thyroid cancer	6.8e-05	0.000271	CcSEcCtD
Ofloxacin—Constipation—Epirubicin—thyroid cancer	6.8e-05	0.000271	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	6.7e-05	0.000268	CcSEcCtD
Ofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	6.67e-05	0.0306	CbGpPWpGaD
Ofloxacin—Insomnia—Doxorubicin—thyroid cancer	6.65e-05	0.000266	CcSEcCtD
Ofloxacin—Paraesthesia—Doxorubicin—thyroid cancer	6.6e-05	0.000264	CcSEcCtD
Ofloxacin—Dyspnoea—Doxorubicin—thyroid cancer	6.55e-05	0.000262	CcSEcCtD
Ofloxacin—Feeling abnormal—Epirubicin—thyroid cancer	6.55e-05	0.000262	CcSEcCtD
Ofloxacin—Somnolence—Doxorubicin—thyroid cancer	6.54e-05	0.000261	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Epirubicin—thyroid cancer	6.5e-05	0.00026	CcSEcCtD
Ofloxacin—Dyspepsia—Doxorubicin—thyroid cancer	6.47e-05	0.000259	CcSEcCtD
Ofloxacin—Decreased appetite—Doxorubicin—thyroid cancer	6.39e-05	0.000255	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	6.35e-05	0.000254	CcSEcCtD
Ofloxacin—Fatigue—Doxorubicin—thyroid cancer	6.34e-05	0.000253	CcSEcCtD
Ofloxacin—Urticaria—Epirubicin—thyroid cancer	6.31e-05	0.000252	CcSEcCtD
Ofloxacin—Pain—Doxorubicin—thyroid cancer	6.29e-05	0.000251	CcSEcCtD
Ofloxacin—Constipation—Doxorubicin—thyroid cancer	6.29e-05	0.000251	CcSEcCtD
Ofloxacin—Abdominal pain—Epirubicin—thyroid cancer	6.28e-05	0.000251	CcSEcCtD
Ofloxacin—Body temperature increased—Epirubicin—thyroid cancer	6.28e-05	0.000251	CcSEcCtD
Ofloxacin—Feeling abnormal—Doxorubicin—thyroid cancer	6.06e-05	0.000242	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Doxorubicin—thyroid cancer	6.01e-05	0.00024	CcSEcCtD
Ofloxacin—Hypersensitivity—Epirubicin—thyroid cancer	5.85e-05	0.000234	CcSEcCtD
Ofloxacin—Urticaria—Doxorubicin—thyroid cancer	5.84e-05	0.000233	CcSEcCtD
Ofloxacin—Abdominal pain—Doxorubicin—thyroid cancer	5.81e-05	0.000232	CcSEcCtD
Ofloxacin—Body temperature increased—Doxorubicin—thyroid cancer	5.81e-05	0.000232	CcSEcCtD
Ofloxacin—Asthenia—Epirubicin—thyroid cancer	5.7e-05	0.000228	CcSEcCtD
Ofloxacin—Pruritus—Epirubicin—thyroid cancer	5.62e-05	0.000225	CcSEcCtD
Ofloxacin—ABCC2—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	5.6e-05	0.0257	CbGpPWpGaD
Ofloxacin—Diarrhoea—Epirubicin—thyroid cancer	5.44e-05	0.000217	CcSEcCtD
Ofloxacin—Hypersensitivity—Doxorubicin—thyroid cancer	5.42e-05	0.000216	CcSEcCtD
Ofloxacin—Asthenia—Doxorubicin—thyroid cancer	5.28e-05	0.000211	CcSEcCtD
Ofloxacin—Dizziness—Epirubicin—thyroid cancer	5.25e-05	0.00021	CcSEcCtD
Ofloxacin—Pruritus—Doxorubicin—thyroid cancer	5.2e-05	0.000208	CcSEcCtD
Ofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NRG1—thyroid cancer	5.08e-05	0.0233	CbGpPWpGaD
Ofloxacin—Vomiting—Epirubicin—thyroid cancer	5.05e-05	0.000202	CcSEcCtD
Ofloxacin—Diarrhoea—Doxorubicin—thyroid cancer	5.03e-05	0.000201	CcSEcCtD
Ofloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	5.01e-05	0.023	CbGpPWpGaD
Ofloxacin—Rash—Epirubicin—thyroid cancer	5.01e-05	0.0002	CcSEcCtD
Ofloxacin—Dermatitis—Epirubicin—thyroid cancer	5.01e-05	0.0002	CcSEcCtD
Ofloxacin—Headache—Epirubicin—thyroid cancer	4.98e-05	0.000199	CcSEcCtD
Ofloxacin—Dizziness—Doxorubicin—thyroid cancer	4.86e-05	0.000194	CcSEcCtD
Ofloxacin—Nausea—Epirubicin—thyroid cancer	4.72e-05	0.000189	CcSEcCtD
Ofloxacin—Vomiting—Doxorubicin—thyroid cancer	4.67e-05	0.000187	CcSEcCtD
Ofloxacin—Rash—Doxorubicin—thyroid cancer	4.64e-05	0.000185	CcSEcCtD
Ofloxacin—Dermatitis—Doxorubicin—thyroid cancer	4.63e-05	0.000185	CcSEcCtD
Ofloxacin—Headache—Doxorubicin—thyroid cancer	4.61e-05	0.000184	CcSEcCtD
Ofloxacin—TOP2A—Circadian rythm related genes—NKX2-1—thyroid cancer	4.54e-05	0.0208	CbGpPWpGaD
Ofloxacin—Nausea—Doxorubicin—thyroid cancer	4.37e-05	0.000174	CcSEcCtD
Ofloxacin—ABCC1—S1P1 pathway—PTGS2—thyroid cancer	4.17e-05	0.0192	CbGpPWpGaD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—HPGD—thyroid cancer	4.07e-05	0.0187	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	3.98e-05	0.0183	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK1—thyroid cancer	3.87e-05	0.0178	CbGpPWpGaD
Ofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	3.78e-05	0.0174	CbGpPWpGaD
Ofloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	3.37e-05	0.0155	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—TPR—thyroid cancer	3.03e-05	0.0139	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—CP—thyroid cancer	3.03e-05	0.0139	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CDK1—thyroid cancer	2.72e-05	0.0125	CbGpPWpGaD
Ofloxacin—TOP2A—Gastric Cancer Network 2—TP53—thyroid cancer	2.42e-05	0.0111	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—PCM1—thyroid cancer	2.41e-05	0.0111	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—CP—thyroid cancer	2.28e-05	0.0105	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—TPR—thyroid cancer	2.28e-05	0.0105	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	2.27e-05	0.0104	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—PCM1—thyroid cancer	2.16e-05	0.00991	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—SLC5A5—thyroid cancer	1.98e-05	0.00909	CbGpPWpGaD
Ofloxacin—ABCC1—Arachidonic acid metabolism—PTGS2—thyroid cancer	1.92e-05	0.00883	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	1.91e-05	0.00879	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—CHST14—thyroid cancer	1.85e-05	0.00851	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—TPR—thyroid cancer	1.72e-05	0.0079	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—CP—thyroid cancer	1.72e-05	0.0079	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	1.71e-05	0.00783	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—RXRA—thyroid cancer	1.66e-05	0.00763	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—thyroid cancer	1.61e-05	0.0074	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—TPR—thyroid cancer	1.54e-05	0.00707	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—CP—thyroid cancer	1.54e-05	0.00707	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	1.53e-05	0.00704	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.52e-05	0.00696	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—TPR—thyroid cancer	1.47e-05	0.00677	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—NRG1—thyroid cancer	1.44e-05	0.0066	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TPR—thyroid cancer	1.32e-05	0.00605	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	1.29e-05	0.00591	CbGpPWpGaD
Ofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	1.27e-05	0.00584	CbGpPWpGaD
Ofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	1.26e-05	0.00581	CbGpPWpGaD
Ofloxacin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—thyroid cancer	1.23e-05	0.00567	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—PPARG—thyroid cancer	1.16e-05	0.00533	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—CP—thyroid cancer	1.16e-05	0.00532	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—TPR—thyroid cancer	1.16e-05	0.00532	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.15e-05	0.0053	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.14e-05	0.00523	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—thyroid cancer	1.13e-05	0.00521	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TRIM24—thyroid cancer	1.07e-05	0.00494	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—thyroid cancer	1.06e-05	0.00488	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—MINPP1—thyroid cancer	1.06e-05	0.00486	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	1.03e-05	0.00473	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CHST14—thyroid cancer	1.01e-05	0.00464	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDK1—thyroid cancer	9.99e-06	0.00459	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—RXRA—thyroid cancer	9.69e-06	0.00445	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TRIM33—thyroid cancer	9.58e-06	0.0044	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	9.51e-06	0.00437	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NDUFA13—thyroid cancer	9e-06	0.00413	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CDK1—thyroid cancer	8.93e-06	0.0041	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—TPR—thyroid cancer	8.74e-06	0.00401	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—CP—thyroid cancer	8.74e-06	0.00401	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.67e-06	0.00398	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.6e-06	0.00395	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	8.59e-06	0.00395	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—TPR—thyroid cancer	8.46e-06	0.00389	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—CP—thyroid cancer	8.46e-06	0.00389	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CHST14—thyroid cancer	8.46e-06	0.00389	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—CP—thyroid cancer	8.37e-06	0.00384	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—TPR—thyroid cancer	8.37e-06	0.00384	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.33e-06	0.00382	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	8.29e-06	0.00381	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.23e-06	0.00378	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—PTEN—thyroid cancer	7.96e-06	0.00366	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	7.81e-06	0.00359	CbGpPWpGaD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	7.3e-06	0.00335	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.28e-06	0.00334	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—HPGD—thyroid cancer	6.82e-06	0.00313	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.54e-06	0.003	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TERT—thyroid cancer	6.44e-06	0.00296	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TCF7L1—thyroid cancer	6.39e-06	0.00294	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	6.37e-06	0.00292	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.34e-06	0.00291	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.26e-06	0.00288	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	6.07e-06	0.00279	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	5.82e-06	0.00267	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	5.66e-06	0.0026	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.53e-06	0.00254	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.5e-06	0.00252	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—RXRA—thyroid cancer	5.47e-06	0.00251	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—TP53—thyroid cancer	5.43e-06	0.0025	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.32e-06	0.00245	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.26e-06	0.00242	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	5.23e-06	0.0024	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	4.78e-06	0.0022	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TPR—thyroid cancer	4.68e-06	0.00215	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PRKAR1A—thyroid cancer	4.6e-06	0.00211	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	4.44e-06	0.00204	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MEN1—thyroid cancer	4.4e-06	0.00202	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—thyroid cancer	4.16e-06	0.00191	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—MINPP1—thyroid cancer	4.02e-06	0.00185	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—TPR—thyroid cancer	3.92e-06	0.0018	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PRKAR1A—thyroid cancer	3.85e-06	0.00177	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CCND1—thyroid cancer	3.72e-06	0.00171	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CALCA—thyroid cancer	3.5e-06	0.00161	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.49e-06	0.0016	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NDUFA13—thyroid cancer	3.42e-06	0.00157	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CHST14—thyroid cancer	3.21e-06	0.00148	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CDK1—thyroid cancer	3.17e-06	0.00146	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SLC5A5—thyroid cancer	2.93e-06	0.00135	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.75e-06	0.00126	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HPGD—thyroid cancer	2.59e-06	0.00119	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NRG1—thyroid cancer	2.54e-06	0.00117	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—RXRA—thyroid cancer	2.46e-06	0.00113	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TP53—thyroid cancer	2.45e-06	0.00113	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.4e-06	0.0011	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TERT—thyroid cancer	2.28e-06	0.00105	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HIF1A—thyroid cancer	2.19e-06	0.001	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.1e-06	0.000965	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—BRAF—thyroid cancer	1.81e-06	0.000831	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PPARG—thyroid cancer	1.56e-06	0.000715	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—TPR—thyroid cancer	1.49e-06	0.000683	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.46e-06	0.000672	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTGS2—thyroid cancer	1.46e-06	0.000671	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.33e-06	0.000609	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTEN—thyroid cancer	1.27e-06	0.000585	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTGS2—thyroid cancer	1.22e-06	0.000562	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NRAS—thyroid cancer	1.14e-06	0.000522	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.11e-06	0.000512	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTEN—thyroid cancer	1.07e-06	0.00049	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.04e-06	0.000479	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—KRAS—thyroid cancer	9.79e-07	0.00045	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—RXRA—thyroid cancer	9.36e-07	0.00043	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.1e-07	0.000418	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HRAS—thyroid cancer	8.32e-07	0.000382	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—AKT1—thyroid cancer	7.35e-07	0.000337	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—AKT1—thyroid cancer	6.15e-07	0.000283	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PPARG—thyroid cancer	5.91e-07	0.000271	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTGS2—thyroid cancer	4.65e-07	0.000214	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTEN—thyroid cancer	4.05e-07	0.000186	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AKT1—thyroid cancer	2.34e-07	0.000107	CbGpPWpGaD
